Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSerco Regulatory News (SRP)

Share Price Information for Serco (SRP)

Share Price is delayed by 15 minutes
Get Live Data
253.20    -0.60 (-0.24%)
Bid:
253.00
Ask:
253.60
Spread: 0.60 (0.237%)
Market Cap: £2.50b
SRP Live PriceLast checked at - London Stock Exchange

Intraday Serco Share Chart

Director/PDMR Shareholding

31 Mar 2025 14:21

RNS Number : 9682C
Serco Group PLC
31 March 2025
 

Serco Group plc (the Company)

 

NOTIFICATION OF TRANSACTIONS OF A PERSON DISCHARGING MANAGERIAL RESPONSIBILITIES (PDMR)

 

The Company notifies the following changes in the interests in the ordinary shares of 2p each (Shares) of a PDMR, arising pursuant to the Equity Settled Bonus Plan (Share Awards) as follows:

 

(i) vesting of an award granted on 28 March 2022 - vesting price £1.5671;

 

Directors

Dividend equivalents

Number of Share Awards Vested

Number of Shares Sold for Tax

Total Number of Shares Retained

Nigel Crossley

5,289

96,273

45,409

50,864

 

(ii) grant of an award on 28 March 2025 at a price of £1.5916 being the average closing price of the Shares over the five Dealing Days prior to the date of grant.

 

Directors

Number of Share Awards Granted

Nigel Crossley

120,036

 

Malus and clawback provisions apply to the Share Awards.

 

This announcement is made in accordance with the requirements of the UK version of the Market Abuse Regulation 596/2014.

 

 

1

 

Details of the person discharging managerial responsibilities/person closely associated

 

a)

 

Name of natural person

Nigel Crossley

2

 

Reason for the notification

 

a)

 

Position/status

 

 

Group Chief Financial Officer

 

b)

 

Initial notification/Amendment

 

 

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

Serco Group plc

b)

 

Legal Entity Identifier code

 

 

549300PT2CIHYN5GWJ21

4

 

Details of the transaction(s) summary table

 

Date of Transaction

Financial Instrument

Identification Code

Place of Transaction

Currency

 

28 March 2025

Ordinary shares of 2 pence each

ISIN: GB0007973794

Outside a trading venue

GBP - British Pound

 

Nature of Transaction

 

 

Price

Volume

Total

 

Grant of Share Awards

£1.5916

120,036

£191,049.30

 

 

Aggregated

£1.5916

120,036

£191,049.30

 

Date of Transaction

Financial Instrument

Identification Code

Place of Transaction

Currency

 

28 March 2025

Ordinary shares of 2 pence each

ISIN: GB0007973794

London Stock Exchange, Main Market (XLON)

GBP - British Pound

 

Nature of Transaction

 

Price

Volume

Total

 

Disposal - Tax Liability

£1.5671

45,409

£71,160.44

 

 

Aggregated

£1.5671

45,409

£71,160.44

 

 

Nickesha Graham-Burrell

Group Company Secretary

31 March 2025

 

 

For further information please contact:

Jamie Hastings, Group Head of Investor Relations, tel: +44 (0) 7718 195 074 or email: jamie.hastings@serco.com

 

Scot Marchbank, Group Communications and Marketing Director, tel: +44 (0) 7958 675 706 or email: scot.marchbank@serco.com  

 

About Serco

Serco brings together the right people, the right technology and the right partners to create innovative solutions that make positive impact and address some of the most urgent and complex challenges facing the modern world. With a primary focus on serving governments globally, Serco's services are powered by more than 50,000 people working across defence, space, migration, justice, healthcare, mobility and customer services. Serco's core capabilities include service design and advisory, resourcing, complex programme management, systems integration, case management, engineering, and asset & facilities management. Underpinned by Serco's unique operating model, Serco drives innovation and supports customers from service discovery through to delivery. More information can be found at www.serco.com.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHUAAORVKUOOAR
Date   Source Headline
5th Jun 20265:36 pmRNSTransaction in Own Shares
29th May 20265:35 pmRNSTransaction in Own Shares and Total Voting Rights
26th May 20267:00 amRNSSerco secures £270m contract from NNUH
22nd May 20265:14 pmRNSTransaction in Own Shares
15th May 20265:24 pmRNSTransaction in Own Shares
8th May 20265:25 pmRNSTransaction in Own Shares
30th Apr 20265:37 pmRNSTransactions in own shares and Total Voting Rights
24th Apr 20265:17 pmRNSTransactions in Own Shares
22nd Apr 20264:00 pmRNSResult of AGM
17th Apr 20265:34 pmRNSTransactions in Own Shares
10th Apr 20265:39 pmRNSTransactions in Own Shares
10th Apr 20263:46 pmRNSDirector/PDMR Shareholding
7th Apr 20265:35 pmRNSDirector/PDMR Shareholding
31st Mar 20265:21 pmRNSTransactions in Own Shares and Total Voting Rights
27th Mar 20263:03 pmRNSDirector/PDMR Shareholding
20th Mar 20265:50 pmRNSTransaction in Own Shares
18th Mar 20265:15 pmRNSHolding(s) in Company
18th Mar 202611:00 amRNSPublication of the 2025 ARA and 2026 Notice of AGM
13th Mar 20265:25 pmRNSTransaction in Own Shares
11th Mar 20265:46 pmRNSTransaction in Own Shares and Total Voting Rights
5th Mar 20267:02 amRNSShare Repurchase Programme
5th Mar 20267:00 amRNS2025 full year results
19th Feb 20265:45 pmRNSHolding(s) in Company
9th Feb 20265:30 pmRNSHolding(s) in Company
5th Feb 202612:30 pmRNSHolding(s) in Company
2nd Feb 20265:45 pmRNSTotal Voting Rights and Capital
29th Jan 20265:30 pmRNSHolding(s) in Company
5th Jan 20265:30 pmRNSHolding(s) in Company
31st Dec 20259:00 amRNSTotal Voting Rights and Capital
31st Dec 20259:00 amRNSTotal Voting Rights and Capital
23rd Dec 20254:00 pmRNSHolding(s) in Company
23rd Dec 20254:00 pmRNSHolding(s) in Company
19th Dec 20257:30 amRNSCancellation of Treasury Shares
19th Dec 20257:30 amRNSCancellation of Treasury Shares
17th Dec 20257:01 amRNSCFO Retirement
17th Dec 20257:00 amRNSSerco pre-close trading update
4th Dec 20257:00 amRNSTransaction in Own Shares
3rd Dec 20254:30 pmRNSBlock listing Interim Review
3rd Dec 20257:00 amRNSTransaction in Own Shares
2nd Dec 20257:00 amRNSTransaction in Own Shares
1st Dec 20257:00 amRNSSerco awarded UK prison contract
28th Nov 20256:20 pmRNSTransactions in own shares and Total Voting Rights
28th Nov 20257:00 amRNSTransaction in Own Shares
27th Nov 20257:00 amRNSTransaction in Own Shares
26th Nov 20257:00 amRNSTransaction in Own Shares
25th Nov 20257:00 amRNSTransaction in Own Shares
24th Nov 20257:00 amRNSTransaction in Own Shares
21st Nov 20257:00 amRNSTransaction in Own Shares
20th Nov 20257:00 amRNSTransaction in Own Shares
19th Nov 20257:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.